LZCIC(SH:600423)2025-10-28 08:30Financial Performance - The company's operating revenue for the third quarter was ¥38,684,970, a decrease of 22.37% compared to ¥52,044,549.57 in the same period last year[7]. - Total profit for the quarter was ¥4,066,988.98, down 73.64% from ¥15,426,015.31 year-on-year[7]. - Net profit attributable to shareholders was ¥3,562,906.67, representing a 76.86% decline from ¥15,399,919.85 in the previous year[7]. - The basic earnings per share decreased by 78.95%, from ¥0.019 to ¥0.004[7]. - The weighted average return on equity fell by 2.19 percentage points to 0.64% for the quarter[7]. - The net profit attributable to shareholders for the year-to-date was ¥7,005,698.71, down 77.44% from ¥31,053,114.12 last year[7]. - Revenue for the first three quarters of 2025 was CNY 106.66 million, a decrease of 13.5% compared to CNY 123.28 million in the same period of 2024[21]. - Operating profit for the first three quarters of 2025 was CNY 8.37 million, down 73.1% from CNY 31.09 million in 2024[21]. - Net profit for the first three quarters of 2025 was CNY 7.01 million, a decline of 77.5% compared to CNY 31.05 million in 2024[21]. - The total profit for the first three quarters of 2025 was CNY 8.37 million, a decrease of 73.0% compared to CNY 31.09 million in 2024[21]. Cash Flow and Assets - The net cash flow from operating activities for the year-to-date was ¥9,543,067.36, a significant drop of 79.10% compared to ¥45,654,478.14 last year[7]. - Cash flow from operating activities for the first three quarters of 2025 was CNY 9.54 million, a decrease of 79.1% compared to CNY 45.65 million in 2024[23]. - Cash and cash equivalents stood at RMB 437,297,359.36, showing a slight increase from RMB 427,761,645.21[18]. - Cash and cash equivalents at the end of the third quarter of 2025 were CNY 435.28 million, an increase from CNY 423.27 million at the end of the same period in 2024[24]. - The company reported a net cash outflow from investing activities of CNY 1.35 million, compared to a net outflow of CNY 4.27 million in 2024[24]. Assets and Liabilities - The total assets at the end of the reporting period increased by 2.66% to ¥618,149,176.04 compared to the end of the previous year[7]. - The company reported a total asset of RMB 618,149,176.04 as of September 30, 2025, an increase from RMB 602,152,226.46 at the end of 2024, reflecting a growth of approximately 2.0%[20]. - The total current assets amounted to RMB 512,459,946.96, up from RMB 496,091,054.12, indicating an increase of about 3.0%[18]. - The company’s total liabilities reached RMB 59,115,674.64, compared to RMB 50,599,518.18 in the previous year, representing an increase of approximately 16.0%[19]. - The company’s total equity amounted to RMB 559,033,501.40, an increase from RMB 551,552,708.28, reflecting a growth of about 1.3%[19]. Operational Challenges - The company attributed the decline in profits primarily to the continued weak demand for hydrogen peroxide and lower market prices compared to the previous year[11]. - The company has a significant reliance on its limited production capacity and single product line, which constrains revenue growth potential in the short term[16]. - The company faces a risk of delisting if annual revenue falls below RMB 30 million and net profit is negative, as per the new Shanghai Stock Exchange rules[16]. Research and Development - Research and development expenses decreased significantly to CNY 0.42 million, down 75.8% from CNY 1.75 million in the previous year[21]. Inventory and Receivables - Accounts receivable increased to RMB 8,662,876.96 from RMB 8,154,672.43, reflecting a growth of about 6.2%[18]. - The company’s inventory decreased to RMB 4,131,281.91 from RMB 4,421,164.00, indicating a reduction of approximately 6.5%[18].